Biovance Capital, Arcano Partners and the EIC Fund invest €11 million in Vaxdyn to advance clinical development
SEVILLE, SPAIN – 7 Sep 2026 – Biovance Capital, the European Innovation Council (EIC) Fund and Arcano Partners’ Impacto Andalucía Innovación y Desarrollo SICC, S.A.U. have invested €11 million in …
